The Joint Corp. Reports 2023 Operating Metrics - Seite 2
Q4 2023 Financial Results Reporting
Management intends to report its fourth quarter and year-end 2023 financial results on Thursday, March 7, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will
hold a conference call at 5:00 p.m. ET that day to discuss the results.
Lesen Sie auch
Forward-Looking Statements
This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and
expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not
statements of historical fact. Words such as, "anticipates," "believes," "continues," "estimates," "expects," "goal," "objectives," "intends," "may," "opportunity," "plans," "potential,"
"near-term," "long-term," "projections," "assumptions," "projects," "guidance," "forecasts," "outlook," "target," "trends," "should," "could," "would," "will," and similar expressions are intended
to identify such forward-looking statements. Specific forward looking statements made in this press release include, among others, our belief that in the fall we began implementing several
initiatives that we expect will improve our 2024 performance and profitability; our plan to drive top-line growth and new patient count by enhancing our promotions, brand positioning, and media
with an increased focus on attracting lapsed patients as well as elongating membership of existing patients; our plan to improve the bottom line by executing our refranchising strategy for the
majority of our corporate clinics; our belief that our recent actions are expected to strengthen the health of our franchise network and increase our ability to reinvest in the business to create
value for our stakeholders. Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other
personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation,
exacerbated by COVID-19 and the current war in Ukraine, which has increased our costs and which could otherwise negatively impact our business; the potential for further disruption to our
operations and the unpredictable impact on our business of the COVID-19 outbreak and outbreaks of other contagious diseases; our failure to profitably operate company-owned or managed clinics;
short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate
future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain
investor confidence; and other factors described in our filings with the SEC, including in the section entitled “Risk Factors” in our Annual Report on Form 10-K/A for the year ended December 31,
2022 filed with the SEC on September 26, 2023 and subsequently filed current and quarterly reports. We qualify any forward-looking statements entirely by these cautionary factors. We assume no
obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking
statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future
performance, unless expressed as such, and should only be viewed as historical data.